Retrovir
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.13 | $68.00 (0%) | 🛒 Add to cart |
| 90 | $1.10 | $102.00 $99.00 (3%) | 🛒 Add to cart |
| 120 | $1.06 | $136.00 $127.00 (7%) | 🛒 Add to cart |
| 180 | $0.98 | $204.00 $176.00 (14%) | 🛒 Add to cart |
| 270 | $0.95 | $306.00 $257.00 (16%) | 🛒 Add to cart |
| 360 | $0.91
Best per pill | $408.00 $328.00 (20%) | 🛒 Add to cart |
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $6.20 | $62.00 (0%) | 🛒 Add to cart |
| 20 | $5.75 | $124.00 $115.00 (7%) | 🛒 Add to cart |
| 30 | $5.37 | $186.00 $161.00 (13%) | 🛒 Add to cart |
| 60 | $5.13 | $372.00 $308.00 (17%) | 🛒 Add to cart |
| 90 | $4.72 | $558.00 $425.00 (24%) | 🛒 Add to cart |
| 120 | $4.50 | $744.00 $540.00 (27%) | 🛒 Add to cart |
| 180 | $4.20 | $1116.00 $756.00 (32%) | 🛒 Add to cart |
| 270 | $4.00 | $1674.00 $1080.00 (35%) | 🛒 Add to cart |
| 360 | $3.85
Best per pill | $2232.00 $1386.00 (38%) | 🛒 Add to cart |
More info:
Alli: Clinically Proven Weight Loss Aid for Sustainable Results
Alli (orlistat 60 mg) is the only FDA-approved over-the-counter weight loss aid that works by blocking the absorption of about 25% of dietary fat. Designed for adults with a BMI of 25 or higher, it complements a reduced-calorie, low-fat diet and regular physical activity to support gradual, sustainable weight management. Backed by extensive clinical research, Alli offers a non-stimulant, non-systemic mechanism of action, making it a trusted option for individuals committed to a structured weight loss journey under appropriate guidance.
Biktarvy: Comprehensive HIV-1 Management in a Single Tablet
Biktarvy represents a significant advancement in the treatment of HIV-1 infection, offering a complete antiretroviral regimen in a single, once-daily tablet. It combines three potent antiretroviral agents—bictegravir, emtricitabine, and tenofovir alafenamide—into a fixed-dose combination designed to achieve and maintain viral suppression with a high barrier to resistance. This integrase strand transfer inhibitor (INSTI)-based regimen is indicated for use in both treatment-naïve adults and virologically suppressed adults seeking to replace their current antiretroviral therapy, providing a streamlined approach to long-term disease management.
Flibanserin: A Targeted Treatment for Acquired, Generalized Hypoactive Sexual Desire Disorder in Premenopausal Women
Flibanserin is a multifunctional serotonin agonist and antagonist (MSAA) approved for the medical management of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. It represents a significant advancement in the neuropharmacological approach to female sexual dysfunction, specifically targeting the complex neurotransmitter imbalances associated with low sexual desire. Unlike therapies that address situational or arousal-phase issues, flibanserin works centrally to rebalance brain chemistry, offering a non-hormonal, daily treatment option for a condition that can significantly impact quality of life and emotional well-being.
Orlistat: Clinically Proven Weight Management Therapy
Orlistat is a lipase inhibitor medication approved for weight management in adults with obesity or overweight with related comorbidities. It functions by blocking the absorption of dietary fats in the intestines, thereby reducing caloric intake. This agent is indicated for use in conjunction with a reduced-calorie diet and is suitable for long-term weight control when combined with lifestyle modifications. Clinical evidence supports its efficacy in promoting weight loss and improving metabolic parameters.
Sustiva: Advanced NNRTI Therapy for Effective HIV-1 Management
Sustiva (efavirenz) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in combination with other antiretroviral agents. As a cornerstone of many highly active antiretroviral therapy (HAART) regimens, it functions by binding directly to reverse transcriptase, blocking RNA-dependent and DNA-dependent DNA polymerase activities. This mechanism effectively suppresses viral replication, reduces plasma HIV-RNA levels, and increases CD4 cell counts. Clinical studies have demonstrated its potent antiviral efficacy, convenient once-daily dosing, and established role in both treatment-naïve and experienced patients, subject to resistance testing.
Acamprol: Restoring Neurochemical Balance for Alcohol Dependence Management
Acamprol (acamprosate calcium) is a clinically validated pharmacotherapy specifically formulated to support abstinence maintenance in alcohol-dependent patients following detoxification. As a synthetic compound with structural similarity to endogenous neurotransmitters, it modulates glutamatergic hyperactivity and GABAergic hypoactivity associated with chronic alcohol exposure. Its targeted mechanism addresses the neuroadaptations underlying craving and withdrawal, offering a physiological foundation for sustained recovery. Acamprol represents an essential component of comprehensive treatment programs when combined with psychosocial interventions.
Accufine: Precision-Engineered Relief for Chronic Neuropathic Pain
Accufine represents a significant advancement in the pharmacological management of moderate to severe chronic neuropathic pain. This prescription medication, containing the active ingredient Pregabalin, is specifically formulated to modulate hyperexcited neurons, targeting the underlying pathophysiology of nerve pain rather than merely masking symptoms. Its development is grounded in extensive clinical research, offering a targeted therapeutic option for patients who have found inadequate relief from conventional analgesics. By binding to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, Accufine reduces the release of several neurotransmitters, thereby decreasing neuronal excitability and providing sustained, reliable pain control.
Accutane: The Definitive Solution for Severe Nodular Acne
Accutane (isotretinoin) is a potent oral retinoid medication specifically formulated for treatment-resistant, severe nodular acne that has proven unresponsive to conventional therapies. As a derivative of vitamin A, it operates through a multi-mechanistic approach targeting the fundamental pathological drivers of acne vulgaris. This prescription-only medication represents the most clinically effective intervention available for recalcitrant cystic acne, offering potential long-term remission where other treatments have failed. Strict medical supervision is mandatory throughout the course of therapy due to its significant teratogenic potential and possible serious adverse effects.
Aciclovir: Effective Antiviral Treatment for Herpes Infections
Aciclovir is a nucleoside analogue antiviral medication specifically designed to manage infections caused by the herpes simplex virus (HSV) and varicella-zoster virus (VZV). As a first-line therapeutic agent, it inhibits viral DNA replication, thereby reducing the severity and duration of outbreaks. Clinically proven and widely prescribed, aciclovir is available in oral, topical, and intravenous formulations to suit varying patient needs and clinical scenarios. Its mechanism of action targets infected cells while sparing healthy ones, offering a favorable safety profile for both episodic treatment and long-term suppressive therapy.